Overview:
Newborns are prone to various diseases such as asthma, chronic obstructive pulmonary disease (COPD), polio, encephaliphitis, epilepsy, diarrhea, anemia, leukemia, and other rare diseases that results in substantial economic burden. Newborn screening helps detect potentially fatal or disabling conditions in infants as early as possible. Newborn screening tests look for genetic, developmental, and metabolic disorders in newborns. These tests have the potential to prevent severe health problems, as well as death.
As per the American Academy of Pediatrics, newborn screening is important to ensure that all infants who are deaf or hard of hearing are identified as early as possible. Three out of every 1,000 children born in the United States have hearing level outside the normal range. Thus, it is important to detect these problems as early as possible, because it makes a big difference in their development.
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/2546
Drivers:
Favorable government initiatives and/or support is expected to augment the growth of the Asia Pacific newborn screening market during the forecast period. Health regulatory bodies focusing on raising public awareness about newborn screening. For instance, in June 2014, PerkinElmer and China’s National Health and Family Planning Commission (NHFPC) signed an agreement to implement a 3-year training program for newborn screening. Moreover, PerkinElmer is also working with the National Maternal and Children Health Surveillance Office (NMCHSO) to increase adoption and availability of newborn screening in China.
Moreover, increasing adoption of newborn screening due to the increasing awareness among people and technological advancements in fluorescence analysis test, colorimetric analysis test, tandem mass spectrometry, enzyme or liquid chromatography, and immunological assays and other analysis are some major factors expected to boost the growth of the Asia Pacific newborn screening market. For instance, in October 2018, LifeCell International announced the launch of ‘RightStart’ – Integrated DNA testing for Newborn Screening (NBS) to detect more than 50 medical conditions. It has been proven to be more accurate than current screening methods.
Restraints:
Dearth of skilled professionals and poor healthcare infrastructure is expected to hinder growth of the Asia Pacific newborn screening market.
Regional Insights:
China is expected to witness robust growth in the Asia Pacific newborn screening market owing to the increasing adoption of newborn screening methods and favorable government initiatives in the region. For instance, China has included hearing loss and Phenylketonuria (PKU) and Congenital Hypothyroidism (CH) in national wide screening program, which is also mandatory for all newborns in China. Moreover, in China, there are approximately 150 newborn screening laboratories offering screening for glucose-6-phosphate dehydrogenase deficiency (G-6-PDD) and congenital adrenal hyperplasia (CAH).
Furthermore, India is expected to witness substantial growth in the market due to high birth rate in this region. For instance, as reported by the World Health Organization (WHO), in 2016, the birth rate in India was around 34 births per second and 2,062 births per hour.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/2546
Competitive landscape:
Major players active in the Asia Pacific newborn screening market are Agilent Technologies, Medtronic plc, AB SCIEX, Covidien PLC, Bio-Rad Laboratories, GE Life Sciences, Natus Medical Inc., Masimo Corporation, PerkinElmer Inc., ZenTech S.A., Trivitron Healthcare Pvt. Ltd., and Waters Technologies Corporation, among others.
Reasons to buy this Asia Pacific Newborn Screening Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Asia Pacific Newborn Screening Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Asia Pacific Newborn Screening Market
◘ Leading company profiles reveal details of key Asia Pacific Newborn Screening Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging Asia Pacific Newborn Screening Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Asia Pacific Newborn Screening Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Asia Pacific Newborn Screening Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
https://www.coherentmarketinsights.com/promo/buynow/2546
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Asia Pacific Newborn Screening Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Asia Pacific Newborn Screening Industry Impact
Chapter 2 Global Asia Pacific Newborn Screening Competition by Types, Applications, and Top Regions and Countries
2.1 Global Asia Pacific Newborn Screening (Volume and Value) by Type
2.3 Global Asia Pacific Newborn Screening (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Asia Pacific Newborn Screening Sales, Consumption, Export, Import by Regions
Chapter 5 North America Asia Pacific Newborn Screening Market Analysis
Chapter 6 East Asia Asia Pacific Newborn Screening Market Analysis
Chapter 7 Europe Asia Pacific Newborn Screening Market Analysis
Chapter 8 South Asia Asia Pacific Newborn Screening Market Analysis
Chapter 9 Southeast Asia Asia Pacific Newborn Screening Market Analysis
Chapter 10 Middle East Asia Pacific Newborn Screening Market Analysis
Chapter 11 Africa Asia Pacific Newborn Screening Market Analysis
Chapter 12 Oceania Asia Pacific Newborn Screening Market Analysis
Chapter 13 South America Asia Pacific Newborn Screening Market Analysis
Chapter 14 Company Profiles and Key Figures in Asia Pacific Newborn Screening Business
Chapter 15 Global Asia Pacific Newborn Screening Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology….
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837